期刊文献+

大黄利胆胶囊治疗胆囊切除术后综合征患者的疗效观察 被引量:11

Observation of the Rhubarb choleretic capsule curative effect on patients with postcholecystectomy syndrome
原文传递
导出
摘要 目的:观察大黄利胆胶囊治疗胆囊术后综合征的临床疗效。方法:144例诊断胆囊术后综合征患者分为观察组及对照组,观察组和对照组分别口服大黄利胆胶囊和消炎利胆片治疗6个月,观察临床疗效及前后VAS评分自身对照。结果:观察组患者主要症状腹痛、恶心较对照组均有明显缓解,总有效率分别为88.9%vs.75.0%(X2=12.517,P=0.000)、97.2%vs.88.9%(X2=4.923,P=0.043)。对照组纳差症状缓解优于观察组,但无统计学差异,86.1%vs.77.0%(X2=1.077,P=0.664)。观察组与对照组患者右上腹胀闷治疗前平均VAS分值无显著差异(7.02 vs.6.14,t=0.621,P=0.933),治疗后平均VAS分别为2.12和4.15,观察组疗效显著优于对照组(t=2.079,P=0.020)。结论:大黄利胆胶囊治疗胆囊术后综合征有确切疗效。 Objective:To investigate the effects of rhubarb choleretic capsule(RCC) on Post-cholecystectomy syndrome(PCS).Methods:144 cases were diagnosed as PCS and were divided into two groups,which were the study group and the control group.Treatment with RCC and Xiaoyan Lidan tablets respectively 6 months to determine the efficacy on clinic symptoms and Visual analogue scales(VAS) via case control study.Results:The main symptomatic outcome of study group are improving more significantly than control group,which efficiency rate of abdominal pain,nausea,are 88.9% vs.75.0%(X2=12.517,P=0.000),97.2% vs.88.9%(X2=4.923,P=0.043),respectively.The anorexia outcome of control group are improving more than study group which are 86.1% vs.77.0%,but no significant difference(X2=1.077,P=0.664).The level of VAS according to right upper abdominal pain of study group are improving more greatly than control study(before-average VAS 7.02 vs.6.14 t=0.621,P=0.933;after-average VAS 2.12 vs.4.15,(t=2.079,P=0.020).Conclusion:Treating PCS with rhubarb choleretic capsule(RCC) has a good effect.
作者 金鑫 史宪杰
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第21期2531-2534,共4页 Chinese Journal of New Drugs
基金 国家自然科学基金(81150031)
关键词 胆囊切除术后胆道功能障碍 大黄利胆胶囊 疗效观察 Rhubarb choleretic capsule post-cholecystectomy syndrome effect observation
  • 相关文献

参考文献11

二级参考文献102

共引文献963

同被引文献92

引证文献11

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部